Concurrently, vaccine-induced titers of binding Abs targeting V1V2, which correlated with a decreased risk of HIV-1 infection, declined over time (Montefiori et al., 2012; Robb et al., 2012; Yates et al., 2014). Here, DDX41 is linked to HIV-1 infection.